AbbVie work hard to address neglected tropical diseases (NTDs) that disproportionately impact the world’s poor and marginalized populations
More than 160 of AbbVie's most experienced scientists are collaborating with partners like A∙WOL and dedicating 17,100 pro-bono hours to drug development projects, advisory boards and compound screening to help solve NTDs.